Apeloa Pharmaceutical's low P/E ratio is justified by expect...
Apeloa Pharmaceutical's low P/E ratio is justified by expected slower growth. Shareholders accept this as they anticipate future earnings may not provide pleasant surprises, potentially limiting a strong share price rise.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more